Mehul is an investor, entrepreneur, and poet focused on building a world we would be happy to be born into at random. He previously founded a venture fund focused on agtech, healthcare, and infrastructure investments. His investments include Greenlight Biosciences (GRNA), Virsec, Apollo, and Mesh++. He previously chaired the Emory Global Health Institute. Mehul regularly writes In the Margins, a newsletter focused on tech & society.